Component
Apo-10-prime-lycopenoic acid
Apo-10-prime-lycopenoic acid. Species, exposure and limitations are retained in each linked claim.
14 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Apo-10-prime-lycopenoic acid did not inhibit differentiation of 3T3-L1 adipocytes.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"}
- experimental_model
- Adipocyte transcription and adipose-tissue experiments
- exposure
- Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid
- limitations
- Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Mouse 3T3-L1 cells and in-vivo adipose model
- plain_language
- Retinoid-related signaling did not mean identical effects to retinoic acid.
- primary_references
- [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
- tissue_or_cell_type
- Adipocyte differentiation and inflammatory gene expression
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 936–947
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Adipocyte transcription and adipose-tissue experiments · source_derived_draft · unverified_draft
### lycopene-apo-adipogenesis-null Apo-10-prime-lycopenoic acid did not inhibit differentiation of 3T3-L1 adipocytes. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Retinoid-related signaling did not mean identical effects to retinoic acid. organism: Mouse 3T3-L1 cells and in-vivo adipose model tissue_or_cell_type: Adipocyte differentiation and inflammatory gene expression experimental_model: Adipocyte transcription and adipose-tissue experiments limitations: Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified. exposure: Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid evidence_span: {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"} [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
Complete structured claim and evidenceThe metabolite prevented increases in IL-6 and IL-1-beta in the studied adipose inflammation models.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"}
- experimental_model
- Adipocyte transcription and adipose-tissue experiments
- exposure
- Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid
- limitations
- Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Mouse 3T3-L1 cells and in-vivo adipose model
- plain_language
- The tested product changed inflammatory responses in preclinical systems.
- primary_references
- [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
- tissue_or_cell_type
- Adipocyte differentiation and inflammatory gene expression
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 949–960
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Adipocyte transcription and adipose-tissue experiments · source_derived_draft · unverified_draft
### lycopene-apo-adipose-cytokines The metabolite prevented increases in IL-6 and IL-1-beta in the studied adipose inflammation models. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The tested product changed inflammatory responses in preclinical systems. organism: Mouse 3T3-L1 cells and in-vivo adipose model tissue_or_cell_type: Adipocyte differentiation and inflammatory gene expression experimental_model: Adipocyte transcription and adipose-tissue experiments limitations: Only part of the transcriptional response overlapped with ATRA; proposed tissue metabolite was not definitively identified. exposure: Apo-10-prime-lycopenoic acid compared with all-trans retinoic acid evidence_span: {"source_cache": "artifacts/lycopene-research/21963687.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45", "start_char": 0, "end_char": 1730, "text_sha256": "1bfc882d0e01b54d1d94c19a457265128c999d8d2ee40cdc6cf6a25de6d32a45"} [lycopene-p21963687] Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. (2011). https://pubmed.ncbi.nlm.nih.gov/21963687/ DOI: 10.1016/j.bbalip.2011.09.002
Complete structured claim and evidenceThe metabolite lowered cyclin E and inhibited G1-to-S progression in the bronchial-cell models.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
- experimental_model
- Cell-cycle assays and NNK-induced mouse tumor model
- exposure
- Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
- limitations
- Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human bronchial cell lines; A/J mice separately specified
- plain_language
- A cell-cycle accelerator decreased.
- primary_references
- [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
- tissue_or_cell_type
- Bronchial epithelium and lung tumors
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 715–726
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft
### lycopene-apo-cyclin The metabolite lowered cyclin E and inhibited G1-to-S progression in the bronchial-cell models. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A cell-cycle accelerator decreased. organism: Human bronchial cell lines; A/J mice separately specified tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
Complete structured claim and evidenceApo-10-prime-lycopenoic acid induced glutamate-cysteine ligases in the bronchial-cell experiment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
- experimental_model
- Metabolite exposure and gene/protein/redox measurements
- exposure
- Time- and dose-dependent apo-10-prime-lycopenoid exposure
- limitations
- Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human BEAS-2B bronchial epithelial cells
- plain_language
- The response included machinery used to make glutathione.
- primary_references
- [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
- tissue_or_cell_type
- Nucleus, antioxidant enzymes and intracellular glutathione
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 533–544
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft
### lycopene-apo-gcl Apo-10-prime-lycopenoic acid induced glutamate-cysteine ligases in the bronchial-cell experiment. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response included machinery used to make glutathione. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
Complete structured claim and evidenceThe metabolite increased total intracellular glutathione in BEAS-2B cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
- experimental_model
- Metabolite exposure and gene/protein/redox measurements
- exposure
- Time- and dose-dependent apo-10-prime-lycopenoid exposure
- limitations
- Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human BEAS-2B bronchial epithelial cells
- plain_language
- A measured glutathione pool rose; this does not show that dietary precursors were sufficient in every tissue.
- primary_references
- [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
- tissue_or_cell_type
- Nucleus, antioxidant enzymes and intracellular glutathione
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 559–570
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft
### lycopene-apo-glutathione The metabolite increased total intracellular glutathione in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A measured glutathione pool rose; this does not show that dietary precursors were sufficient in every tissue. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
Complete structured claim and evidenceApo-10-prime-lycopenoic acid induced glutathione S-transferases in BEAS-2B cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
- experimental_model
- Metabolite exposure and gene/protein/redox measurements
- exposure
- Time- and dose-dependent apo-10-prime-lycopenoid exposure
- limitations
- Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human BEAS-2B bronchial epithelial cells
- plain_language
- Some responding enzymes use glutathione in conjugation reactions.
- primary_references
- [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
- tissue_or_cell_type
- Nucleus, antioxidant enzymes and intracellular glutathione
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 546–557
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft
### lycopene-apo-gst Apo-10-prime-lycopenoic acid induced glutathione S-transferases in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Some responding enzymes use glutathione in conjugation reactions. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
Complete structured claim and evidenceApo-10-prime-lycopenoic acid induced heme oxygenase-1 in bronchial epithelial cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
- experimental_model
- Metabolite exposure and gene/protein/redox measurements
- exposure
- Time- and dose-dependent apo-10-prime-lycopenoid exposure
- limitations
- Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human BEAS-2B bronchial epithelial cells
- plain_language
- One responding enzyme handles heme turnover.
- primary_references
- [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
- tissue_or_cell_type
- Nucleus, antioxidant enzymes and intracellular glutathione
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 507–518
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft
### lycopene-apo-hmox1 Apo-10-prime-lycopenoic acid induced heme oxygenase-1 in bronchial epithelial cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: One responding enzyme handles heme turnover. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
Complete structured claim and evidenceMean tumors per mouse fell from 16 with NNK alone to 10, 7 and 5 across ascending metabolite diet doses.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
- experimental_model
- Cell-cycle assays and NNK-induced mouse tumor model
- exposure
- Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
- limitations
- Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- A/J mouse
- plain_language
- The animal result is a research lead, not demonstrated human cancer prevention.
- primary_references
- [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
- tissue_or_cell_type
- Bronchial epithelium and lung tumors
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 754–765
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft
### lycopene-apo-mouse-tumors Mean tumors per mouse fell from 16 with NNK alone to 10, 7 and 5 across ascending metabolite diet doses. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The animal result is a research lead, not demonstrated human cancer prevention. organism: A/J mouse tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
Complete structured claim and evidenceApo-10-prime-lycopenoic acid induced NQO1 in BEAS-2B cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
- experimental_model
- Metabolite exposure and gene/protein/redox measurements
- exposure
- Time- and dose-dependent apo-10-prime-lycopenoid exposure
- limitations
- Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human BEAS-2B bronchial epithelial cells
- plain_language
- This shares a protective enzyme node with other compounds already in the ledger.
- primary_references
- [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
- tissue_or_cell_type
- Nucleus, antioxidant enzymes and intracellular glutathione
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 520–531
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft
### lycopene-apo-nqo1 Apo-10-prime-lycopenoic acid induced NQO1 in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: This shares a protective enzyme node with other compounds already in the ledger. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
Complete structured claim and evidenceApo-10-prime-lycopenoic acid increased nuclear Nrf2 accumulation in BEAS-2B cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
- experimental_model
- Metabolite exposure and gene/protein/redox measurements
- exposure
- Time- and dose-dependent apo-10-prime-lycopenoid exposure
- limitations
- Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human BEAS-2B bronchial epithelial cells
- plain_language
- A defined breakdown product activated the Nrf2-associated response.
- primary_references
- [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
- tissue_or_cell_type
- Nucleus, antioxidant enzymes and intracellular glutathione
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 494–505
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft
### lycopene-apo-nrf2 Apo-10-prime-lycopenoic acid increased nuclear Nrf2 accumulation in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A defined breakdown product activated the Nrf2-associated response. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
Complete structured claim and evidenceThe metabolite suppressed endogenous ROS generation and hydrogen-peroxide-induced injury in BEAS-2B cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"}
- experimental_model
- Metabolite exposure and gene/protein/redox measurements
- exposure
- Time- and dose-dependent apo-10-prime-lycopenoid exposure
- limitations
- Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human BEAS-2B bronchial epithelial cells
- plain_language
- Cells were less vulnerable to the tested oxidant exposure.
- primary_references
- [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
- tissue_or_cell_type
- Nucleus, antioxidant enzymes and intracellular glutathione
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 572–583
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolite exposure and gene/protein/redox measurements · source_derived_draft · unverified_draft
### lycopene-apo-oxidant-injury The metabolite suppressed endogenous ROS generation and hydrogen-peroxide-induced injury in BEAS-2B cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Cells were less vulnerable to the tested oxidant exposure. organism: Human BEAS-2B bronchial epithelial cells tissue_or_cell_type: Nucleus, antioxidant enzymes and intracellular glutathione experimental_model: Metabolite exposure and gene/protein/redox measurements limitations: Cell-culture metabolite results do not prove oral lycopene reaches equivalent tissue concentrations or prevents human cancer. exposure: Time- and dose-dependent apo-10-prime-lycopenoid exposure evidence_span: {"source_cache": "artifacts/lycopene-research/18566994.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534", "start_char": 0, "end_char": 1416, "text_sha256": "e34a21bb159c3e48372fd5cb104bfa50572903a5ef168b10100976a718b7b534"} [lycopene-p18566994] Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18566994/ DOI: 10.1002/ijc.23696
Complete structured claim and evidenceThe metabolite increased p21 and p27 protein in the tested bronchial cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
- experimental_model
- Cell-cycle assays and NNK-induced mouse tumor model
- exposure
- Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
- limitations
- Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human bronchial cell lines; A/J mice separately specified
- plain_language
- Proteins that restrain cell-cycle progression increased.
- primary_references
- [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
- tissue_or_cell_type
- Bronchial epithelium and lung tumors
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 728–739
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft
### lycopene-apo-p21-p27 The metabolite increased p21 and p27 protein in the tested bronchial cells. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Proteins that restrain cell-cycle progression increased. organism: Human bronchial cell lines; A/J mice separately specified tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
Complete structured claim and evidenceApo-10-prime-lycopenoic acid activated the RAR-beta promoter and increased RAR-beta expression.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"}
- experimental_model
- Cell-cycle assays and NNK-induced mouse tumor model
- exposure
- Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg
- limitations
- Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human bronchial cell lines; A/J mice separately specified
- plain_language
- A lycopene product can intersect retinoid signaling without becoming vitamin A.
- primary_references
- [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
- tissue_or_cell_type
- Bronchial epithelium and lung tumors
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 741–752
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-cycle assays and NNK-induced mouse tumor model · source_derived_draft · unverified_draft
### lycopene-apo-rarb Apo-10-prime-lycopenoic acid activated the RAR-beta promoter and increased RAR-beta expression. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: A lycopene product can intersect retinoid signaling without becoming vitamin A. organism: Human bronchial cell lines; A/J mice separately specified tissue_or_cell_type: Bronchial epithelium and lung tumors experimental_model: Cell-cycle assays and NNK-induced mouse tumor model limitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival. exposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg evidence_span: {"source_cache": "artifacts/lycopene-research/17420169.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c", "start_char": 0, "end_char": 1675, "text_sha256": "84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c"} [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076
Complete structured claim and evidence
What acts on it
NAD+ supported conversion of apo-10-prime-lycopenal to apo-10-prime-lycopenoic acid in ferret hepatic fractions.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"}
- experimental_model
- Recombinant ferret enzyme and tissue-fraction metabolism
- exposure
- 5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH
- limitations
- Ferret experiments do not quantify human cleavage flux or predict supplement response.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Ferret
- plain_language
- The oxidized niacin-derived cofactor helped steer the aldehyde toward an acid.
- primary_references
- [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
- tissue_or_cell_type
- BCO2 enzyme; hepatic fractions and lung
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 338–349
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant ferret enzyme and tissue-fraction metabolism · source_derived_draft · unverified_draft
### lycopene-apo-nad NAD+ supported conversion of apo-10-prime-lycopenal to apo-10-prime-lycopenoic acid in ferret hepatic fractions. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: The oxidized niacin-derived cofactor helped steer the aldehyde toward an acid. organism: Ferret tissue_or_cell_type: BCO2 enzyme; hepatic fractions and lung experimental_model: Recombinant ferret enzyme and tissue-fraction metabolism limitations: Ferret experiments do not quantify human cleavage flux or predict supplement response. exposure: 5-cis, 13-cis and all-trans lycopene; iron; NAD+ or NADH evidence_span: {"source_cache": "artifacts/lycopene-research/16672231.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445", "start_char": 0, "end_char": 1967, "text_sha256": "135695c9d3106469d8d64ec0806ba5bf048f0f1df6f3e3cd53e838e50b960445"} [lycopene-p16672231] The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. (2006). https://pubmed.ncbi.nlm.nih.gov/16672231/ DOI: 10.1074/jbc.m512095200
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.